A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2002
The purpose of this clinical research study is to assess the safety and effectiveness of entecavir, as compared to lamivudine, in the treatment of adults with chronic hepatitis B infection who are hepatitis B e antigen negative.
Epistemonikos ID: b8c10b8b34117d6b44612807c87c5283b6897dcf
First added on: Nov 24, 2021